Medifast, Inc. (MED) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Medifast, Inc. (MED) Consumer Business Overview

Medifast, Inc. (MED) is a consumer cyclical company focused on weight management and healthy living products, primarily marketed through its OPTAVIA program. With a presence in the US and Asia-Pacific, Medifast faces competition in a dynamic market driven by evolving consumer preferences and health trends.

What Is the Investment Thesis for MED?

Medifast, Inc. presents a mixed investment case. The company's gross margin of 70.1% indicates strong pricing power. However, a negative profit margin of -5.8% raises concerns about operational efficiency and cost management. The company's beta of 0.56 suggests lower volatility compared to the market. Growth catalysts include expansion in the Asia-Pacific market and continued innovation in product offerings. Potential risks include increased competition in the weight loss industry and fluctuations in consumer spending. Investors should closely monitor Medifast's ability to improve profitability and maintain market share in a competitive environment.

Based on FMP financials and quantitative analysis

MED Key Highlights

Market capitalization of $132M, reflecting its current valuation in the market.

• Gross margin of 70.1%, indicating strong pricing power and efficient cost of goods sold management.
• Negative profit margin of -5.8%, suggesting challenges in managing operating expenses and achieving profitability.
• Beta of 0.56, indicating lower volatility compared to the broader market.
• Operates in the Consumer Cyclical sector, making it sensitive to economic cycles and consumer spending patterns.

Who Are MED's Competitors?

MED is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are MED's Key Strengths?

Established brand reputation in the weight loss industry.

• Proprietary OPTAVIA program with a network of independent coaches.
• High gross margin of 70.1%.
• Direct-to-consumer sales model through e-commerce platform.

What Are MED's Weaknesses?

Negative profit margin of -5.8%.

• Dependence on independent coaches for sales and customer support.
• Limited geographic presence compared to larger competitors.
• Vulnerability to changing consumer preferences and health trends.

What Could Drive MED Stock Higher?

Potential positive impact from new product launches in the health and wellness category.

• Continued expansion of the OPTAVIA program and its network of independent coaches.
• Growth in e-commerce sales and digital marketing initiatives.

What Are the Key Risks for MED?

Negative return on equity (-9.7%) — the business is not currently generating profit on shareholder capital.

• Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
• Increased competition from other weight loss programs and nutritional product manufacturers.
• Fluctuations in consumer spending and economic cycles.
• Negative profit margin impacting overall financial performance.
• Regulatory changes and shifting consumer attitudes towards health and wellness.

What Are the Growth Opportunities for MED?

• Expansion in the Asia-Pacific Market: Medifast has the opportunity to further expand its presence in the Asia-Pacific region, tapping into a large and growing market for weight management products. This expansion could involve strategic partnerships, localized product offerings, and targeted marketing campaigns. Timeline: Ongoing.
• Product Innovation and New Product Development: Medifast can drive growth through continuous product innovation and the development of new offerings that cater to evolving consumer preferences. This includes exploring new flavors, formats, and ingredients, as well as incorporating technological advancements into its products and services. The market for innovative health and wellness products is constantly expanding, with consumers seeking convenient and effective solutions. Timeline: Ongoing.
• Enhancement of the OPTAVIA Program: Medifast can further enhance its OPTAVIA program by incorporating personalized coaching, digital tools, and community support. This includes leveraging data analytics to provide customized recommendations and tracking progress. The OPTAVIA program's success depends on its ability to deliver tangible results and foster long-term behavior change. The market for personalized health and wellness solutions is growing rapidly. Timeline: Ongoing.
• Strategic Partnerships and Collaborations: Medifast can pursue strategic partnerships and collaborations with complementary businesses, such as fitness centers, healthcare providers, and corporate wellness programs. These partnerships can expand its reach and provide access to new customer segments. The market for integrated health and wellness solutions is gaining traction, with consumers seeking comprehensive approaches to health management. Timeline: Ongoing.
• E-commerce Optimization and Digital Marketing: Medifast can optimize its e-commerce platform and digital marketing efforts to enhance customer acquisition and retention. This includes improving website usability, leveraging social media marketing, and implementing targeted advertising campaigns. The e-commerce channel is crucial for Medifast's growth, with online sales accounting for a significant portion of its revenue. The market for online health and wellness products is highly competitive. Timeline: Ongoing.

What Are MED's Competitive Advantages?

• Brand recognition and reputation in the weight loss industry.
• Proprietary OPTAVIA program with a network of independent coaches.
• Established e-commerce platform for direct-to-consumer sales.
• Formulation and branding of consumable health and nutritional products.

What Does MED Do?

Founded in 1980 and headquartered in Baltimore, Maryland, Medifast, Inc. has evolved into a prominent player in the weight loss and healthy living sector. The company manufactures and distributes a range of products designed for weight loss, weight management, and overall health. Its product portfolio includes bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups. These products are marketed under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. Medifast primarily utilizes an e-commerce platform to reach its customers, facilitating direct-to-consumer sales and personalized coaching through its OPTAVIA program. The company operates in the United States and the Asia-Pacific region, catering to a diverse customer base seeking weight management solutions and healthier lifestyles. Medifast's business model emphasizes a holistic approach to weight loss, combining nutritional products with coaching and community support.

What Products and Services Does MED Offer?

• Manufactures weight loss, weight management, and healthy living products.
• Distributes products in the United States and the Asia-Pacific region.
• Offers a range of products including bars, shakes, soups, and snacks.
• Markets products under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands.
• Utilizes an e-commerce platform for direct-to-consumer sales.
• Provides coaching and community support through the OPTAVIA program.

How Does MED Make Money?

• Direct-to-consumer sales through its e-commerce platform.
• Network of independent OPTAVIA coaches who provide personalized support and guidance.
• Subscription-based model for recurring product purchases.
• Emphasis on community and social support to enhance customer engagement and retention.

What Industry Does MED Operate In?

Medifast operates within the competitive personal products and services industry, which is characterized by evolving consumer preferences and health trends. The market for weight loss and weight management products is substantial, driven by increasing health awareness and obesity rates. Medifast competes with other weight loss programs, nutritional product manufacturers, and direct-to-consumer health companies. The industry is also influenced by regulatory changes and shifting consumer attitudes towards health and wellness. Medifast's success depends on its ability to differentiate its products, maintain customer loyalty, and adapt to changing market dynamics.

Who Are MED's Key Customers?

• Individuals seeking weight loss and weight management solutions.
• Health-conscious consumers looking for healthy living products.
• Customers in the United States and the Asia-Pacific region.
• Individuals seeking personalized coaching and support through the OPTAVIA program.

Over the past six months, Medifast, Inc. insiders filed 21 SEC Form 4 transactions — 6 sales and 15 purchases. On net that is roughly 172K shares acquired (about $7K) — insiders putting money in tends to read as conviction.

Wall Street analysts project Medifast, Inc. revenue of about $287.7M for fiscal 2026, with EPS near $-1.15.

Medifast, Inc. has beaten Wall Street's EPS estimate in 7 of its last 8 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 134.6% below estimates on average.

Medifast, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 3.85 places it in the safe zone, indicating low near-term bankruptcy risk.

Return on equity for Medifast, Inc. stands at -9.7%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -7.9%, showing how much profit it generates from its asset base. Its free cash flow yield is -1.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 4.80 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -16.6%, the inverse of the P/E and a quick read on earnings relative to price.

Medifast, Inc. (MED) Valuation Context

Valued at $132M, MED is classified as a micro-cap stock. Relative to its peer group, MED's quantitative score of 45/100 is roughly in line with the peer average of 44/100.

MED Revenue & Earnings Trend

In Q2 2026, MED generated $76.4M in top-line revenue, marking a sequential increase of 0.4%. The company recorded a net loss of $3.1M, with diluted EPS of $-0.28. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this micro-cap Consumer Cyclical company. Across the four most recent quarters, MED averaged $-0.58 in diluted EPS.

Company Profile

Medifast, Inc. operates in the Specialty Business Services industry within the Consumer Cyclical sector. It is headquartered in Baltimore, US. The company is led by CEO Nicholas Johnson. MED has traded publicly since 1993.

MED Financials

MED Latest News

MED Analyst Consensus

MED MoonshotScore

MED Consumer Cyclical Stock FAQ

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources